זינט תרחיף 250 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 50 mg/ml ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organism.
פורטום 2 גרם
novartis israel ltd., israel - ceftazidime as pentahydrate - אבקה להמסה להזרקה\אינפוזיה - ceftazidime as pentahydrate 2 g/vial - ceftazidime - ceftazidime - treatment of single or multiple infections caused by susceptible micro-organisms.
פורטום 1 גרם
novartis israel ltd., israel - ceftazidime as pentahydrate - אבקה להמסה להזרקה\אינפוזיה - ceftazidime as pentahydrate 1 g/vial - ceftazidime - ceftazidime - treatment of single or multiple infections caused by susceptible micro-organisms.
אקסג'ייד 125 מג
novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 125 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).
אקסג'ייד 500 מג
novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 500 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).
אקסג'ייד 250 מג
novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 250 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).
זינט טבליות 500 מג
novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 500 mg - cefuroxime
פולבסטרנט סנדוז
novartis israel ltd - fulvestrant - תמיסה להזרקה - fulvestrant 50 mg/ml - fulvestrant
טייקרב
novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.
קווטיאפין סנדוז 150 מג פי. אר.טי
novartis israel ltd - quetiapine as fumarate - טבליות בשחרור ממושך - quetiapine as fumarate 150 mg - quetiapine